arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

CervoMed Inc.

CRVO

$2.87 ▲ +0.12 (+4.18%) at close

14 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

CervoMed Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $25.9M

Dividend Yield —

Revenue Growth -58.9% ↘

Op. Margin None

ROIC -122.7% ↘

FCF / Share $-2.59 ↘

Trailing P/E —

Price / Book 1.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$4.01M

↓ -58.9% —

Net Income Profit after all expenses

$-26.97M

↓ -65.5% —

Operating Margin Operating profit as % of sales

-187.2%

↓ -71.2% —

FCF / Share Free cash flow per share

$-2.59

↓ -26.7% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗
Revenue Growth YoY (%)	-58.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-836%)	36.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+354%)	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-47.5% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-146.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	92.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-4380.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	16.7% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	83.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	78.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-159.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-79.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-65.5% Weak ↑ Weak Improving Year-over-year change in net income	-650.1% Weak ↓ Weak Declining Year-over-year change in net income	62.6% Excellent ↑ Excellent Improving Year-over-year change in net income	75.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-69.9% Weak ↑ Weak Improving Year-over-year change in net income	-20.2% Weak ↑ Weak Improving Year-over-year change in net income	35.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-1246.2% Weak ↓ Weak Declining Year-over-year change in net income	92.4% Excellent ↑ Excellent Improving Year-over-year change in net income	24.3% Good ↑ Good Improving Year-over-year change in net income	-66.0% Weak ↑ Weak Improving Year-over-year change in net income	-483.9% Weak Weak Year-over-year change in net income	70.8% Excellent Excellent Year-over-year change in net income	—
FCF Growth YoY (%)	-26.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	26.8% Excellent Excellent Year-over-year change in free cash flow	43.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	78.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-1367.2% Weak Weak Year-over-year change in free cash flow	-103.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗
Operating Margin (%) (%)	—	-187.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1348%)	-109.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-829%)	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	1.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	10.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	43.6% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	16.4% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	—	-167.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1494%)	-30.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-353%)	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	-169.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-104.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	3.43x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	9.37x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.24x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗
Return on Invested Capital (%)	-122.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-83.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	8.2% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	-69.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-57.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-59.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-118.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-30.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-196.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-32.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-156.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-123.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-42.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-78.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-83.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-65.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-57.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-47.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-104.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-105.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-119.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-69.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-137.0% Weak Weak Operating profit relative to total assets Optimal: > 10%
Return on Common Equity (%) (%)	-148.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1087%)	-41.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-377%)	-29.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-296%)	17.4% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+16%)	-69.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-560%)	-57.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-481%)	-58.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-491%)	-117.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-884%)	-6.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-196.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1409%)	—	-37.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-351%)	-38.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-354%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗
Interest Coverage (x)	—	—	—	-5920.84x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-6319.58x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-113.48x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-496.53x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-53.43x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-101.17x Weak Weak Operating income divided by interest expense Optimal: > 5x	-93.83x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$-8.24M	$-9.00M	$-7.79M	$-4.09M	$-37.31M	$-18.52M	$-14.18M	$-7.99M	$-8.90M	$-1.55M	$-12.01M	$-312.09K	$-254.96K	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗
Revenue per Share (USD)	$0.44	$1.21	$2.68	$0.00	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-2.98	$-2.02	$-0.82	$-11.20	$-0.25	$-0.30	$-1.76	$-8.21	$-3.16	$-1.76	—	—	—	—
Free Cash Flow per Share (USD)	$-2.59	$-2.05	$-2.80	$-4.97	—	—	—	$-3.32	$-15.44	$-1.05	$-0.52	—	—	—
Book Value per Share (USD)	$1.97	$4.50	$1.30	$-64.24	$0.34	$0.39	$0.60	$4.62	$21.93	$0.89	—	$42.84	$1.11	—
Tangible Book Value per Share (USD)	$1.97	$4.50	$1.30	$-64.24	$0.34	$0.39	$0.60	$4.62	$14.77	$0.22	—	$22.07	$-1.53	—
Basic Weighted Avg Shares (shares)	9.04M	8.07M	2.66M	518,140	—	—	—	3.24M	827,575	10.23M	18.61M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗
Working Capital (USD)	$18.22M	$39.20M	—	—	$34.90M	$16.34M	$12.93M	$8.11M	$6.98M	$-2.83M	$10.97M	$21.83M	$-5.88M	$-4.32M
Total Equity (USD)	$18.22M	$39.20M	$7.38M	$-33.29M	$34.91M	$24.81M	$20.13M	$15.61M	$21.23M	$9.18M	—	$38.17M	$6.46M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	$4.01M	$9.74M	$7.14M	$0.00	—	—	—	—	—	—	—	—	—	$40.19K
Depreciation Expense (USD)	—	—	—	—	$93.42K	$103.17K	$97.92K	$110.37K	$67.98K	$25.34K	$23.27K	$566.26K	$116.45K	$49.67K
Net Income, GAAP (USD)	$-26.97M	$-16.29M	$-2.17M	$-5.80M	$-24.10M	$-14.19M	$-11.80M	$-18.37M	$-1.36M	$-18.04M	$-23.82M	$-14.35M	$-2.46M	$-8.41M
Operating Cash Flow (USD)	$-23.45M	$-16.53M	$-7.45M	$-2.57M	$-14.50M	$-13.55M	$-9.86M	$-10.77M	$-12.33M	$-10.77M	$-9.60M	$-9.03M	$-1.18M	$-1.98M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 57 quarters

CervoMed Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CRVO with peers